Sphingosine‐1‐phosphate receptor 2

Sphingosine‐1‐phosphate (S1P) is a potent bioactive sphingolipid involved in cell proliferation, angiogenesis, inflammation and malignant transformation among other functions. S1P acts either directly on intracellular targets or activates G protein‐coupled receptors, specifically five S1P receptors (S1PRs). The identified S1PRs differ in cellular and tissue distribution, and each is coupled to specific G proteins, which mediate unique functions. Here, we describe functional characteristics of all five receptors, emphasizing S1PR2, which is critical in the immune, nervous, metabolic, cardiovascular, musculoskeletal, and renal systems. This review also describes the role of this receptor in tumor growth and metastasis and suggests potential therapeutic avenues that exploit S1PR2.

[1]  Y. Hannun,et al.  Epidermal growth factor‐induced cellular invasion requires sphingosine‐1‐phosphate/sphingosine‐1‐phosphate 2 receptor‐mediated ezrin activation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  J. Marvel,et al.  S1PR5 is pivotal for the homeostasis of patrolling monocytes , 2013, European journal of immunology.

[3]  J. Zhao,et al.  Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury. , 2012, American journal of respiratory cell and molecular biology.

[4]  Liping Huang,et al.  Dendritic Cell Sphingosine 1-Phosphate Receptor-3 Regulates Th1–Th2 Polarity in Kidney Ischemia–Reperfusion Injury , 2012, The Journal of Immunology.

[5]  D. Geerts,et al.  Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier , 2012, Journal of Neuroinflammation.

[6]  S. Mehrotra,et al.  Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis , 2012, EMBO molecular medicine.

[7]  A. Yamaguchi,et al.  Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells , 2012, PloS one.

[8]  E. Hoffman,et al.  Sphingosine-1-Phosphate Enhances Satellite Cell Activation in Dystrophic Muscles through a S1PR2/STAT3 Signaling Pathway , 2012, PloS one.

[9]  Peiqing Liu,et al.  S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition. , 2012, Experimental cell research.

[10]  C. Klinge,et al.  Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells. , 2012, International journal of oncology.

[11]  Hongxia Liu,et al.  LPS and TNF-α induce expression of sphingosine-1-phosphate receptor-2 in human microvascular endothelial cells. , 2012, Pathology, research and practice.

[12]  K. Brown,et al.  Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. , 2012, Journal of the American Society of Nephrology : JASN.

[13]  S. Spiegel,et al.  Conjugated bile acids activate the sphingosine‐1‐phosphate receptor 2 in primary rodent hepatocytes , 2012, Hepatology.

[14]  Lihua Huang,et al.  Senescent endothelial dysfunction is attributed to the up-regulation of sphingosine-1-phosphate receptor-2 in aged rats , 2012, Molecular and Cellular Biochemistry.

[15]  J. Chun,et al.  Frequent spontaneous seizures followed by spatial working memory/anxiety deficits in mice lacking sphingosine 1-phosphate receptor 2 , 2011, Epilepsy & Behavior.

[16]  J. Marvel,et al.  Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking. , 2011, Blood.

[17]  M. Lipp,et al.  Sphingosine‐1‐phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17‐cell differentiation in a murine model , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Charles P. Lin,et al.  FTY720 Blocks Egress of T Cells in Part by Abrogation of Their Adhesion on the Lymph Node Sinus , 2011, The Journal of Immunology.

[19]  J. Newcombe,et al.  Sphingosine Kinase 1 and Sphingosine 1-Phosphate Receptor 3 Are Functionally Upregulated on Astrocytes under Pro-Inflammatory Conditions , 2011, PloS one.

[20]  L. Obeid,et al.  Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy , 2011, Critical reviews in biochemistry and molecular biology.

[21]  Y. Hannun,et al.  Many Ceramides* , 2011, The Journal of Biological Chemistry.

[22]  L. Obeid,et al.  Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. , 2011, Blood.

[23]  M. Del Poeta,et al.  Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages. , 2011, Microbiology.

[24]  B. Weinstock-Guttman,et al.  Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis , 2011, Advances in therapy.

[25]  S. Salomone,et al.  Selectivity and Specificity of Sphingosine-1-Phosphate Receptor Ligands: Caveats and Critical Thinking in Characterizing Receptor-Mediated Effects , 2011, Front. Pharmacol..

[26]  B. Levkau,et al.  Sphingosine-1-Phosphate Receptor 3 Promotes Recruitment of Monocyte/Macrophages in Inflammation and Atherosclerosis , 2011, Circulation research.

[27]  Peter Natesan Pushparaj,et al.  Dissecting the Role of the S1P/S1PR Axis in Health and Disease , 2011, Journal of dental research.

[28]  C. Lingwood.  Glycosphingolipid functions. , 2011, Cold Spring Harbor perspectives in biology.

[29]  E. Kremmer,et al.  Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine‐1‐phosphate receptor S1P4 , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  H. Sakai,et al.  Downregulation of sphingosine-1-phosphate receptors in bronchial smooth muscle of mouse experimental asthma. , 2010, Pharmacological research.

[31]  J. Kroetsch,et al.  Sphingosine-1-Phosphate–Dependent Activation of p38 MAPK Maintains Elevated Peripheral Resistance in Heart Failure Through Increased Myogenic Vasoconstriction , 2010, Circulation research.

[32]  Y. Fujiwara,et al.  Sphingosine 1-Phosphate Receptor 4 Uses HER2 (ERBB2) to Regulate Extracellular Signal Regulated Kinase-1/2 in MDA-MB-453 Breast Cancer Cells* , 2010, The Journal of Biological Chemistry.

[33]  D. Verzijl,et al.  Sphingosine 1‐phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions , 2010, Glia.

[34]  D. Staus,et al.  Sphingosine 1-Phosphate Receptor 2 Signals Through Leukemia-Associated RhoGEF (LARG), to Promote Smooth Muscle Cell Differentiation , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[35]  R. Proia,et al.  Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. , 2010, The Journal of clinical investigation.

[36]  Yong-En Xie,et al.  Effect of S1P5 on proliferation and migration of human esophageal cancer cells. , 2010, World journal of gastroenterology.

[37]  N. Mochizuki,et al.  Sphingosine 1-Phosphate (S1P) Regulates Vascular Contraction via S1P3 Receptor: Investigation Based on a New S1P3 Receptor Antagonist , 2010, Molecular Pharmacology.

[38]  S. Milstien,et al.  Essential roles of sphingosine-1–phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema , 2010, The Journal of experimental medicine.

[39]  J. Chun,et al.  Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells. , 2010, Biochemical and biophysical research communications.

[40]  T. Hornemann,et al.  Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids*♦ , 2010, The Journal of Biological Chemistry.

[41]  T. Hla,et al.  Inhibitory Role of Sphingosine 1-Phosphate Receptor 2 in Macrophage Recruitment during Inflammation , 2009, The Journal of Immunology.

[42]  L. Pasqualucci,et al.  Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. , 2009, Cancer research.

[43]  J. Chun,et al.  T-bet–dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow , 2009, The Journal of experimental medicine.

[44]  Takuya Shimizu,et al.  Sphingosine-1-Phosphate Receptor-2 Regulates Expression of Smooth Muscle Alpha-Actin After Arterial Injury , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[45]  M. Ho,et al.  S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells. , 2009, American journal of physiology. Cell physiology.

[46]  T. Hla,et al.  S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. , 2009, Cancer letters.

[47]  A. Merrill,et al.  Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-Deoxysphinganine , 2009, Journal of Biological Chemistry.

[48]  T. Ohmori,et al.  Antagonism of Sphingosine 1-Phosphate Receptor-2 Enhances Migration of Neural Progenitor Cells Toward an Area of Brain Infarction , 2008, Stroke.

[49]  Harshini Sarojini,et al.  Up-regulating Sphingosine 1-Phosphate Receptor-2 Signaling Impairs Chemotactic, Wound-healing, and Morphogenetic Responses in Senescent Endothelial Cells* , 2008, Journal of Biological Chemistry.

[50]  T. Hla,et al.  Induction of Antiproliferative Connective Tissue Growth Factor Expression in Wilms' Tumor Cells by Sphingosine-1-Phosphate Receptor 2 , 2008, Molecular Cancer Research.

[51]  R. Proia,et al.  The alliance of sphingosine-1-phosphate and its receptors in immunity , 2008, Nature Reviews Immunology.

[52]  S. Kaneko,et al.  G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. , 2008, Cardiovascular research.

[53]  Yong Song Gho,et al.  Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. , 2008, Blood.

[54]  S. Milstien,et al.  “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets , 2008, Pharmacological Reviews.

[55]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[56]  Y. Gho,et al.  Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/G i /PLC/Ca 2 (cid:1) signaling pathways , 2008 .

[57]  Yannick Jacques,et al.  Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor , 2007, Nature Immunology.

[58]  Takuya Shimizu,et al.  Sphingosine 1-Phosphate Receptor 2 Negatively Regulates Neointimal Formation in Mouse Arteries , 2007, Circulation research.

[59]  S. Spiegel,et al.  Sphingosine kinase 1 , 2007 .

[60]  R. Proia,et al.  Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. , 2007, The Journal of clinical investigation.

[61]  T. Hla,et al.  Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor–2 (S1P2R) and its Downstream Effectors ROCK and PTEN , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[62]  L. Obeid,et al.  Activation of sphingosine‐1‐phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[63]  R. Proia,et al.  Deafness and Stria Vascularis Defects in S1P2 Receptor-null Mice* , 2007, Journal of Biological Chemistry.

[64]  J. Lorenz,et al.  Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[65]  S. Payne,et al.  Role of ABCC1 in export of sphingosine-1-phosphate from mast cells , 2006, Proceedings of the National Academy of Sciences.

[66]  Andrew S. Holmes,et al.  Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1 , 2006, The Journal of cell biology.

[67]  K. Miyazawa,et al.  Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. , 2006, Arthritis and rheumatism.

[68]  Mitra Poulami,et al.  マスト細胞からのスフィンゴシン‐1‐りん酸の運び出しに果たすABCC1の役割 , 2006 .

[69]  E. Goetzl,et al.  Type 4 sphingosine 1‐phosphate G protein‐coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[70]  Fernando Ferrer,et al.  The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. , 2005, Cancer research.

[71]  M. Pangalos,et al.  Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival , 2005, The Journal of Neuroscience.

[72]  S. Chae,et al.  Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. , 2004, The Journal of clinical investigation.

[73]  J. Cyster,et al.  FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[74]  L. Obeid,et al.  Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. , 2004, Biochimica et biophysica acta.

[75]  R. Proia,et al.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.

[76]  H. Nagawa,et al.  Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. , 2003, The Biochemical journal.

[77]  N. Sugimoto,et al.  Ligand-dependent Inhibition of B16 Melanoma Cell Migration and Invasion via Endogenous S1P2 G Protein-coupled Receptor , 2003, Journal of Biological Chemistry.

[78]  T. Gudermann,et al.  The sphingosine 1‐phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13 , 2003, Journal of cellular biochemistry.

[79]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[80]  有川 佳代.  Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor , 2003 .

[81]  E. Goetzl,et al.  Activation‐regulated expression and chemotactic function of sphingosine 1‐phosphate receptors in mouse splenic T cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  L. Formigli,et al.  Sphingosine 1-phosphate evokes calcium signals in C2C12 myoblasts via Edg3 and Edg5 receptors. , 2002, The Biochemical journal.

[83]  Y. Hannun,et al.  Cystic Fibrosis Transmembrane Regulator Regulates Uptake of Sphingoid Base Phosphates and Lysophosphatidic Acid , 2001, The Journal of Biological Chemistry.

[84]  B. Friedman,et al.  Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein-coupled Receptor, LPB3/EDG-3* , 2001, The Journal of Biological Chemistry.

[85]  S. Roper,et al.  An essential role for the H218/AGR16/Edg‐5/LPB2 sphingosine 1‐phosphate receptor in neuronal excitability , 2001, The European journal of neuroscience.

[86]  J. P. Hobson,et al.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.

[87]  S. Spiegel.  Sphingosine 1‐Phosphate: A Ligand for the EDG‐1 Family of G‐Protein‐Coupled Receptors , 2000, Annals of the New York Academy of Sciences.

[88]  T. Bleu,et al.  Sphingosine 1-Phosphate-induced Cell Proliferation, Survival, and Related Signaling Events Mediated by G Protein-coupled Receptors Edg3 and Edg5* , 2000, The Journal of Biological Chemistry.

[89]  M. Lipp,et al.  EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. , 1998, Genomics.

[90]  C. H. Liu,et al.  Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.

[91]  S. Brenner,et al.  Molecular cloning of the novel human G protein-coupled receptor (GPCR) gene mapped on chromosome 9. , 1996, Biochemical and biophysical research communications.

[92]  Chunyi Zhang,et al.  Activation of a High Affinity G Protein-coupled Plasma Membrane Receptor by Sphingosine-1-phosphate (*) , 1996, The Journal of Biological Chemistry.

[93]  S. Spiegel,et al.  Involvement of a Pertussis Toxin-sensitive G Protein in the Mitogenic Signaling Pathways of Sphingosine 1-Phosphate (*) , 1995, The Journal of Biological Chemistry.

[94]  N. Ishizaka,et al.  Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system. , 1993, Biochemical and biophysical research communications.

[95]  T. Hla,et al.  An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. , 1990, The Journal of biological chemistry.